Cargando…
Effect of NZ2114 against Streptococcus dysgalactiae biofilms and its application in murine mastitis model
Bovine mastitis caused by Streptococcus dysgalactiae (S. dysgalactiae) is usually treated with antibiotics, which may potentially increase drug resistance as the abuse. NZ2114, a variant of fungal defensin plectasin, displayed a potent antibacterial activity against S. dysgalactiae. The inhibition/e...
Autores principales: | Yang, Na, Zhang, Qingjuan, Mao, Ruoyu, Hao, Ya, Ma, Xuanxuan, Teng, Da, Fan, Huan, Wang, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521165/ https://www.ncbi.nlm.nih.gov/pubmed/36187987 http://dx.doi.org/10.3389/fmicb.2022.1010148 |
Ejemplares similares
-
In vitro and in vivo antibacterial effect of NZ2114 against Streptococcus suis type 2 infection in mice peritonitis models
por: Jiao, Jian, et al.
Publicado: (2017) -
Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo
por: Wang, Xiao, et al.
Publicado: (2018) -
Design and pharmacodynamics of recombinant NZ2114 histidine mutants with improved activity against methicillin-resistant Staphylococcus aureus
por: Chen, Huixian, et al.
Publicado: (2017) -
Comparative Genomic Analysis of Streptococcus dysgalactiae subspecies dysgalactiae Isolated From Bovine Mastitis in China
por: Xu, Siyu, et al.
Publicado: (2021) -
Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33
por: Mao, Ruoyu, et al.
Publicado: (2015)